These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36123713)

  • 21. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS).
    Montero JL; Pozo JC; Barrera P; Fraga E; Costán G; Domínguez JL; Muntané J; Rodriguez-Ariza A; Pleguezuelo M; Rufián S; López-Cillero P; de la Mata M
    Transplant Proc; 2006 Oct; 38(8):2511-3. PubMed ID: 17097984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MARS therapy in critically ill patients with advanced malignancy: a clinical and technical report.
    Tan HK; Lim JS; Tan CK; Ng HS; Chow P; Lui HF; Wong GC; Tan PH; Raghuram J; Ng HN; Choong LH; Wong KS; Woo KT
    Liver Int; 2003; 23 Suppl 3():52-60. PubMed ID: 12950962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Albumin dialysis in patients with acute exacerbation of chronic liver failure in an intensive care unit].
    Moragues Ribes C; Cases Viedma E; Ruano Marco M
    Med Clin (Barc); 2006 Nov; 127(17):641-4. PubMed ID: 17169279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular adsorbent recirculating system as a liver support system: summary of Mexican experience.
    Cisneros-Garza LE; Muñoz-Ramírez Mdel R; Muñoz-Espinoza LE; Ruiz Velasco JA; Moreno-Alcántar R; Marín-López E; Méndez-Sánchez N
    Ann Hepatol; 2014; 13(2):240-7. PubMed ID: 24552866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MARS dialysis in decompensated alcoholic liver disease: a single-center experience.
    Wolff B; Machill K; Schumacher D; Schulzki I
    Liver Transpl; 2007 Aug; 13(8):1189-92. PubMed ID: 17663393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience.
    Doria C; Mandalá L; Scott VL; Gruttadauria S; Marino IR
    Dig Dis Sci; 2006 Jan; 51(1):47-53. PubMed ID: 16416211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is MARS system enough for A. phalloides-induced liver failure treatment?
    Sorodoc L; Lionte C; Sorodoc V; Petris O; Jaba I
    Hum Exp Toxicol; 2010 Oct; 29(10):823-32. PubMed ID: 20179021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    Gerth HU; Pohlen M; Thölking G; Pavenstädt H; Brand M; Wilms C; Hüsing-Kabar A; Görlich D; Kabar I; Schmidt HH
    PLoS One; 2017; 12(4):e0175529. PubMed ID: 28403210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.
    Vaid A; Chweich H; Balk EM; Jaber BL
    ASAIO J; 2012; 58(1):51-9. PubMed ID: 22210651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
    Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
    Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
    Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial.
    Saliba F; Camus C; Durand F; Mathurin P; Letierce A; Delafosse B; Barange K; Perrigault PF; Belnard M; Ichaï P; Samuel D
    Ann Intern Med; 2013 Oct; 159(8):522-31. PubMed ID: 24126646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland.
    Kantola T; Ilmakunnas M; Koivusalo AM; Isoniemi H
    Scand J Surg; 2011; 100(1):8-13. PubMed ID: 21482500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.
    Kantola T; Mäklin S; Koivusalo AM; Räsänen P; Rissanen A; Roine R; Sintonen H; Höckerstedt K; Isoniemi H
    World J Gastroenterol; 2010 May; 16(18):2227-34. PubMed ID: 20458759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
    Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
    Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
    Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the molecular adsorbents recirculating system (MARS) in liver failure.
    Sen S; Mookerjee RP; Davies NA; Williams R; Jalan R
    Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():32-8. PubMed ID: 12423451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial liver support systems.
    Tandon R; Froghi S
    J Gastroenterol Hepatol; 2021 May; 36(5):1164-1179. PubMed ID: 32918840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients.
    Inderbitzin D; Muggli B; Ringger A; Beldi G; Gass M; Gloor B; Uehlinger D; Regli B; Reichen J; Candinas D
    J Gastrointest Surg; 2005 Nov; 9(8):1155-61; discussion 1161-2. PubMed ID: 16269387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
    Chiu A; Chan LM; Fan ST
    Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.